Buy One Get One free -Llimited Time Offer X
Imatib A is a prescription medicine that is available as a Capsule. Chronic Myelogenous Leukemia are some of its major therapeutic uses. Other than this, Imatib A has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Imatib A depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Imatib A have been listed ahead. These side effects of Imatib A are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Imatib A has a Severe effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Imatib A's effects on the liver, heart and kidney, if any, have been listed below.
The section on Imatib A contraindications lists all such conditions.
Additionally, Imatib A may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Imatib A is not safe while driving, and is is not addictive in nature.
Imatib A is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Imatib A is used -
Severe
Moderate
Mild
Is the use of Imatib A safe for pregnant women?
Imatib A can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Imatib A safe during breastfeeding?
Imatib A may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Imatib A, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Imatib A.
What is the effect of Imatib A on the Kidneys?
Imatib A can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Imatib A on the Liver?
Imatib A has very mild side effects on the liver.
What is the effect of Imatib A on the Heart?
The heart can be affected by Imatib A. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Imatib A should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imatib A unless your doctor advises you to do so -
Is this Imatib A habit forming or addictive?
Imatib A is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Imatib A, you should not drive or work on any heavy machine, as Imatib A can make you drowsy.
Is it safe?
Imatib A is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Imatib A is not used to treat mental disorders.
Interaction between Food and Imatib A
It is safe to take Imatib A with food.
Interaction between Alcohol and Imatib A
It is difficult to say anything about the effect of Imatib A and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869